Call for proposals for personalising health and care H2020-PHC-2015-single-stage Closed!


The Framework Programme for Research and Innovation (2014-2020) is implemented by specific programme and work programmes.

The “Societal challenges” responds directly to the policy priorities and societal challenges that are identified in the Europe 2020 strategy and that aim to stimulate the critical mass of research and innovation efforts needed to achieve the Union's policy goals.

The specific objective is to fully exploit the potential of Europe's talent pool and to ensure that the benefits of an innovation-led economy are both maximised and widely distributed across the Union in accordance with the principle of excellence.

Funding shall be focused on the following specific objectives:
(a) Health, demographic change and well-being.
(b) Food security, sustainable agriculture and forestry, marine, maritime and inland water research. and the bioeconomy.
(c) Secure, clean and efficient energy.
(d) Smart, green and integrated transport.
(e) Climate action, environment, resource efficiency and raw materials.
(f) Europe in a changing world - Inclusive, innovative and reflective societies.
(g) Secure societies - Protecting freedom and security of Europe and its citizens.


Actions foreseen within this call for proposals include the following topics:

  • PHC-15-2015: Clinical research on regenerative medicine. Translating basic knowledge on regenerative medicine into the clinic is held up by the difficulty in undertaking ‘first in man’ studies. Specific research is needed for proving safety, efficacy and repeatability of new treatments. The, very often iterative, dialogue between the relevant authorities and those developing regenerative medicine approaches is needed before specific regulatory requirements can be established. As a new therapeutic field lacking established business models, financing is a particular obstacle to clinical-stage research in regenerative medicine. The challenge is to initiate a specific action to overcome this hurdle to in-patient research and to determine the potential of new regenerative therapies
  • PHC-21-2015: Advancing active and healthy ageing with ICT: Early risk detection and intervention. Citizens in an ageing European population are at greater risk of cognitive impairment, frailty and social exclusion with considerable negative consequences for their quality of life, that of those who care for them, and for the sustainability of health and care systems. The earlier detection of risks associated with ageing, using ICT approaches, can enable earlier intervention to ameliorate their negative consequences.
  • PHC-25-2015: Advanced ICT systems and services for integrated care. Research on new models of care organisation demonstrates that advanced ICT systems and services may have the potential to respond to, amongst others, the increasing burden of chronic disease and the complexity of co-morbidities and in doing so contribute to the sustainability of health and care systems. One challenge in re-designing health and care systems is to develop integrated care models that are more closely oriented to the needs of patients and older persons: multidisciplinary, well-coordinated, anchored in community and home care settings, and shifting from a reactive approach to proactive and patient-centred care.
  • PHC-27-2015: Self-management of health and disease and patient empowerment supported by ICT. Empowering citizens and patients to manage their own health and disease can result in more cost-effective healthcare systems by enabling the management of chronic diseases outside institutions, improving health outcomes, and by encouraging healthy citizens to remain so. Several clinical situations would be prevented or better monitored and managed with the participation of the patient him or herself. Care sciences may complement the medical perspective without increasing the cost. This requires research into socio-economic and environmental factors and cultural values, behavioural and social models, attitudes and aspirations in relation to personalised health technologies, mobile and/or portable and other new tools, co-operative ICTs, new diagnostics, sensors and devices (including software) for monitoring and personalised services and interventions which promote a healthy lifestyle, wellbeing, mental health, prevention and self-care, improved citizen/healthcare professional interaction and personalised programmes for disease management. Support for knowledge infrastructures is also required. Implementation of programs or applications for different target populations to capture gender- and age-dependent differences in health, behaviour and handling of devices is encouraged.
  • PHC-29-2015: Public procurement of innovative eHealth services. The sustainability of pilot and demonstration solutions and services is broadly perceived as one of the biggest challenges in streamlining healthcare delivery processes and in improving cost efficiency while maintaining or improving patient safety. The pace of development has been slow and penetration of ICT still has high growth potential in healthcare compared to other public or private sectors. This activity facilitates public purchasing of innovative solutions in healthcare which have not yet been deployed on a large scale.
  • PHC-30-2015: Digital representation of health data to improve disease diagnosis and treatment. Digital personalised models, tools and standards with application for some specific clinical targets are currently available. There is however a need for greater integration of patient information, for example of multi-scale and multi-level physiological models with current and historical patient specific data and population specific data, to generate new clinical information for patient management. Any such integrative digital representation (Digital Patient) must also allow meaningful knowledge extraction and decision support.
  • PHC-09-2015: PHC 9 – 2015: Vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS. Vaccines offer a safe and cost-effective way to protect large populations against infectious diseases, or at least to mitigate the clinical course of these diseases. Furthermore, they may in combination with other treatment modalities contribute to an eradicative cure for HIV. Many poverty-related and neglected infectious diseases however continue to escape attempts to develop effective vaccines against them. Disappointing results of recent clinical trials point to bottlenecks in identifying viable candidate vaccines, which if unaddressed will continue to present significant risks of failure at relatively late stages of the development process. The specific challenge will be to shift this ‘risk curve’ in order to better select successful vaccine candidates (and discard those with a higher risk of failure) at an earlier stage of the vaccine development process, for preventive as well as therapeutic vaccines.
  • PHC-28-2015: Self management of health and disease and decision support systems based on predictive computer modelling used by the patient. him or herself. Several clinical situations would be prevented or better monitored and managed with the participation of the patient him or herself. In order to promote the self-management, predictive personalised models can be combined with personal health systems and other sources of data (clinical, biological, therapeutic, behavioural, environmental or occupational exposure, lifestyle and diet etc.) and used by the patient him or herself, in order to raise individual awareness and empower the patient to participate in the management of his or her health, with application in lifestyle, wellbeing and prevention, in monitoring of the disease etc. This will improve the quality of life of patients and the self-management of disease and lifestyle.

European community funding

The Community provisional funding available for the call for proposals is:

  • 162,00 Million EUR (Global Budget)

All the important deadlines

  • 21 April 2015 - 6 years ago (Deadline for the presentation of proposals)

Further information about the call

Official webpage of the call

Useful documents

  • Personalising health and care (Legal base)

Organisations eligible to participate

Opened to the following bodies or institutes with legal status established in the covered areas:

  • Any legal organisation

Covered areas

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

  • European Union (EU)

Directorate-Generale responsible

Directorate-General for Research

Related calls for proposals

Related calls

Explore other programmes